SUCAMPO PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Net
SUCAMPO PHARMACEUTICALS, INC. had Finite-Lived Intangible Assets, Net of $107.88 million as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2017-11-01
- 2017-09-30: Finite-Lived Intangible Assets, Net $107.88M.
- 2017-06-30: Finite-Lived Intangible Assets, Net $114.63M.
- 2017-03-31: Finite-Lived Intangible Assets, Net $121.38M.
- 2016-12-31: Finite-Lived Intangible Assets, Net $128.13M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2017-09-30 | $107.88M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $114.63M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $121.38M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $128.13M 10-Q · filed 2017-11-01 |
| 2016-09-30 | $134.89M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $139.35M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $133.60M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $130.31M 10-K · filed 2017-03-08 |
| 2014-12-31 | $151.00K 10-K · filed 2017-03-08 |